Impact of DNA-Encoded Chemical Library Technology on Drug Discovery

Michelle Keller; Kristina Schira; Jörg Scheuermann

doi:10.2533/chimia.2022.388

Authors

Michelle Keller Dept. of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zürich https://orcid.org/0000-0002-3996-4240
Kristina Schira Dept. of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zürich https://orcid.org/0000-0002-6548-331X
Jörg Scheuermann Dept. of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zürich https://orcid.org/0000-0001-7746-4717

DOI:

https://doi.org/10.2533/chimia.2022.388

PMID:

38069709

Keywords:

DNA-Encoded Chemical Library, small-molecule drug discovery, affinity-based screening

Abstract

DNA-Encoded Chemical Libraries (DELs) have gained momentum over the recent years for the discovery of small-molecule ligands and the technology has been integrated in most of the larger pharmaceutical companies. With this perspective we would like to summarize the development of DEL technology and present some representative DEL-derived hits which may soon enter the pharmaceutical market.

Funding data

Krebsliga Schweiz
Grant numbers KSF-5012-02-2020
H2020 Marie Skłodowska-Curie Actions
Grant numbers 861316

Impact of DNA-Encoded Chemical Library Technology on Drug Discovery

Authors

DOI:

PMID:

Keywords:

Abstract

Funding data

Downloads

Published

How to Cite

Issue

Section

License

Make a Submission

oa

socialmedia

Follow CHIMIA on Social Media

Sections

Information

Current Issue